Arcadia Biosciences (RKDA)
(Delayed Data from NSDQ)
$2.68 USD
-0.25 (-8.53%)
Updated Aug 2, 2024 03:49 PM ET
After-Market: $2.77 +0.09 (3.36%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Price, Consensus and EPS Surprise
RKDA 2.68 -0.25(-8.53%)
Will RKDA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RKDA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RKDA
Arcadia Biosciences (RKDA) Upgraded to Strong Buy: Here's What You Should Know
Arcadia Biosciences (RKDA) Sells GoodWheat Brand to Above Food
RKDA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Arcadia Biosciences (RKDA) Shares Gain on Q1 Earnings Beat
Arcadia Biosciences (RKDA) Reports Q1 Loss, Tops Revenue Estimates
Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Other News for RKDA
Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2024 Financial Results and Business Highlights Conference Call
Arcadia Biosciences (RKDA) Announces Leadership Transition
Optimizing Growth: Arcadia Biosciences’ Strategic Divestitures and Expanding Market Share
Arcadia Biosciences price target lowered by $4 at H.C. Wainwright, here's why
RKDA and YSG among Consumer Staples movers